跳至主要内容
临床试验/ACTRN12615001044516
ACTRN12615001044516尚未招募4 期

A pilot study of the effects of Methylphenidate (MPD) on cognition, mood, behaviour, participation and quality of life after severe traumatic brain injury in adults

Royal Rehab0 个研究点目标入组 20 人开始时间: 2015年10月7日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
Royal Rehab
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • A participant is identified to be eligible if they are aged between 18-65yo, have a new traumatic brain injury within the past 6 months, a measurable PTA of greater than 7 days.
  • All participants need to be able to give informed consent.

排除标准

  • Non-English speaking
  • Current treatment with psycho-active medications
  • cardiac events
  • hypertension
  • abnormal ECG
  • post-traumatic seizures
  • pregnancy (negative bhCG)
  • prior history of alcohol or drug abuse
  • Any medications which are contra-indicated with MPD: monoamine oxidase inhibitors, clonidine, dopamine agonists or antagonists, certain anaesthetics

研究者

发起方
Royal Rehab

相似试验